R 170591

Request For Quotation
R 170591 Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: DC Chemicals  
Tel: 021-58447131 13564518121
Email: doncunbiosci@gmail.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Guangzhou Ruidi Biotechnology Co., Ltd.  
Tel: 020-82099279 18988941402
Email: sales@ubiochem.com

R 170591 manufacturers

  • JNJ-2408068
  • JNJ-2408068 pictures
  • $2500.00
  • 2026-07-27
  • CAS:317846-22-3
  • Purity:
  • Supply Ability: 10g
R 170591 Basic information
Product Name:R 170591
Synonyms:JNJ 2408068;R 170591;2-[[2-[[1-(2-aminoethyl)piperidin-4-yl]amino]-4-methylbenzimidazol-1-yl]methyl]-6-methylpyridin-3-ol;3-Pyridinol, 2-[[2-[[1-(2-aminoethyl)-4-piperidinyl]amino]-4-methyl-1H-benzimidazol-1-yl]methyl]-6-methyl-;HE 066500;HE066500;HE-066500;JNJ2408068,JNJ 2408068
CAS:317846-22-3
MF:C22H30N6O
MW:394.51
EINECS:
Product Categories:
Mol File:317846-22-3.mol
R 170591 Structure
R 170591 Chemical Properties
Boiling point 658.3±65.0 °C(Predicted)
density 1.31±0.1 g/cm3(Predicted)
pka9.19±0.10(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
R 170591 Usage And Synthesis
UsesJNJ 2408068 is a potent RSV (respiratory syncytial virus) inhibitor. JNJ 2408068 significantly inhibits replication of RSV A and B subtypes in the lungs of cotton rats without any evidence of toxicity. The minimum protective dose of JNJ 2408068 appears to be approximately 0.39 mg/kg[1].
References[1] Wyde PR, et al. Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection. Antiviral Res. 2003 Nov;60(3):221-31. DOI:10.1016/j.antiviral.2003.07.002
R 170591 Preparation Products And Raw materials
Tag:R 170591(317846-22-3) Related Product Information
R 170591 2-((5-(hydroxyMethyl)-2-((3-Morpholinopropyl)aMino)-1H-benzo[d]iMidazol-1-yl)Methyl)-6-Methylpyridin-3-ol FUSION GLYCOPROTEIN F0/F protein, HRSV (AFX60213, SF9, HIS) GLYCOPROTEIN/G protein, HRSV (258A.A, HEK293, HIS) Motavizumab Verdinexor (KPT-335)